Triastek completes $20.4 million funding round to accelerate commercialisation of 3D printing pharmaceutical technologies

"Supporting groundbreaking companies like Triastek enables our family capital to achieve high-quality inheritance while making valuable contributions to society.”


Want to discuss? Join the conversation on the TCT Additive Manufacturing Network.  

Get your FREE print subscription to TCT Magazine.

Exhibit at the UK's definitive and most influential 3D printing and additive manufacturing event, TCT 3Sixty.